- 2022 American Transplant Congress - Size to Fit: A Simple Formula to Predict Donor Liver Weight in Deceased Donor Liver Transplant*Purpose: Estimated donor liver volume (DLV) prediction equations are widely published. However, they often are complex and underpredict DLV, particularly in non-ideal body weight donors.…
- 2022 American Transplant Congress - Outcomes of Kidney Transplantation from a Male Donor with a Highly Elevated Prostate Specific Antigen Level (PSA) in Female Recipients- Center for Transplantation, University Medical Center of Southern Nevada, Las Vegas, NV *Purpose: Donor derived malignancy is a contraindication for kidney transplantation. Published literature is devoid of instances of utilization of organs from donors with high PSA…
- 2022 American Transplant Congress - ABO Hemagglutination Titres Do Not Accurately Reflect ABO Antibody Levels*Purpose: ABO antibody (ABO-Ab) quantification is essential for risk assessment for ABO-incompatible (ABOi) transplantation, but the hemagglutination assay (HA) for ABO-Ab titres is known to…
- 2022 American Transplant Congress - Donor-Derived Carbapenem-Resistant Gram-Negative Infections: Risk Mitigation Strategy in Solid Organ Transplant Improves Recipients Safety and Could Expand Donor Pool*Purpose: We implemented an Active Surveillance System (ASS) to mitigate the risk of unexpected carbapenem-resistant Gram-negative (CRGN) donor-derived infection (DDI) in solid organ transplant recipient…
- 2022 American Transplant Congress - Prospective Study of Preimplantation Biopsy in Deceased Donor Kidney Transplantation (DDKT)*Purpose: Our aim was to study the impact of preimplantation biopsy (Bx) findings in selecting kidneys from more marginal donors.*Methods: This is a 2-year prospective…
- 2022 American Transplant Congress - Myeloid Molecular Signature of Ischemia-Reperfusion Injury in Human Liver Transplantation*Purpose: Ischemia reperfusion injury (IRI) is well-appreciated as a significant clinical concern for recipients of liver transplantation, yet there are still no diagnostic or therapeutic…
- 2022 American Transplant Congress - Can We Predict Progression of Potential Donation After Cardiac Death Donors (DCD) Using DonorNet?*Purpose: DCD utilization of livers is limited by unpredictability of progression, perceived worse outcome, and costs related to deployment of resources. We aimed to predict…
- 2022 American Transplant Congress - Reassessment of Previous Kidney Discards from a Single Large Organ Procurement Organization- 1David Geffen School of Medicine, Los Angeles, CA, 2One Legacy, Los Angeles, CA *Purpose: After deceased donor kidneys are recovered, they are offered according to UNOS policy and are discarded if no centers in the country would use…
- 2022 American Transplant Congress - Organ Transplantation From Donors With Active Sars-cov-2 Infection: The Italian Experience*Purpose: In the present study we want to report safety and outcome of organ transplantation from donors with active SARS-CoV-2 infection in Italy.*Methods: In November…
- 2022 American Transplant Congress - Miami Protocol for Liver Deceased Donors After Circulatory Death: Increased 1-year Overall Survival for Selected Patients- University of Miami, Jackson Memorial Hospital, Miami Transplant Institute, Miami, FL *Purpose: The use of deceased donors after circulatory death (DCD) for liver transplantation (LT) is still underutilized. It provides an acceptable solution to increase the…
- 1
- 2
- 3
- …
- 9
- Next Page »
